Were committed to offering insights, guidance, and treatments that cater to your specific needs
But for millions of people already weighing whether to start a GLP-1 drug for diabetes, obesity or another approved indication, it is one more factor worth considering
I listened to thoughtful podcasts from trusted clinicians, reviewed the actual research, and most importantly, heard firsthand from people using these medicationsnot just about weight loss, but about their whole-body benefits and life-changing effects
Overall, the ES paradigms affected behavior in 82.00% of the cases, this was consistent across the behavioral domains assessed (depressive-like behavior 82.35%, anxiety-like behavior 78.57%, cognitive deficits 85.00% and social deficits 80.00% and other ES-induced behaviors 90.00%)
it is often given as a dietary supplement